Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity

Ataee, M; Mirhosseini, S; Mirnejad, R; Rezaie, E; Hosseini, H; Amani, J

Hosseini, H; Amani, J (通讯作者)，Baqiyatallah Univ Med Sci, Syst Biol & Poisonings Inst, Appl Microbiol Res Ctr, Tehran, Iran.

RESEARCH IN PHARMACEUTICAL SCIENCES, 2022; 17 (4): 428

Abstract

Background and purpose: The lack of a new effective treatment for small cell lung cancer (SCLC) is an unresolved problem. Due to the new identificatio......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索